K E Y W O R D S blood vessels cytoskeleton spleen lymph nodes lymphatic tissue smooth muscle SPLEENS AND LYMPH NODES display a compartmentalized structure that is based on a skeleton built up by reticular cells in red pulp, marginal zone, and periarteriolar lymphatic sheet (PALS) and by follicular dendritic cells (FDCs) in follicles and germinal centers. This structural organization directs lymphocyte traffic and interaction as well as antigen and chemokine flow (Veerman and van Ewijk 1975; Nolte et al. 2003; Bajénoff et al. 2006 ; for review see Balogh et al. 2008; Lokmic et al. 2008) . FDCs in germinal centers trap and retain immune complexes and promote affinity maturation of B-cells (Aydar et al. 2005) . The reticular network must permit great volume changes during an immune response, e.g., associated with the development and regression of germinal centers (Veerman and Vries 1976; Liu et al. 1991; Hollowood and Macartney 1992) . Accordingly, contractile proteins characteristic of smooth muscle are expressed by reticular cells (Pinkus et al. 1986; Toccanier-Pelte et al. 1987; Satoh et al. 1997 Satoh et al. ,2009 Steiniger et al. 2001) .
Caldesmon is a thin filament-associated actin-, myosin-, tropomyosin-, and calmodulin-binding protein (for review see Sobue and Sellers 1991; Huber 1997; Dabrowska et al. 2004; Wang 2008) . Low-molecularmass isoforms of caldesmon (l-caldesmon, 70 to 80 kDa) are thought to be widely distributed in nonmuscle tissues, but only a few studies have used immunohistochemistry to investigate the distribution of caldesmon in selected tissues Fujita et al. 1984; Ishimura et al. 1984) . l-Caldesmon has a role in the organization and stabilization of the microfilament network, thus regulating proliferation and migration (Kordowska et al. 2006; Yokouchi et al. 2006; Morita et al. 2007 ). High-molecular-mass isoforms (h-caldesmon, 120 to 150 kDa) are predominantly expressed in differentiated smooth-muscle cells (SMCs), with only a few reported exceptions; platelets, colorectal pericryptal fibroblasts, and myoepithelial cells of galactophorous sinuses of human breast tissue contain h-caldesmon as well (Kakiuchi et al. 1983; Frid et al. 1992; Lazard et al. 1993; Nakayama et al. 1999) . In vitro studies suggest that h-caldesmon modulates the contraction of smooth muscle by inhibiting actomyosin ATPase. The inhibitory effect of h-caldesmon on smoothmuscle contraction can be reversed by binding to Ca 21 / calmodulin or by phosphorylation of caldesmon (Ngai and Walsh 1984; Horiuchi et al. 1986; Mak et al. 1991; Foster et al. 2000 ; for review see Arner and Pfitzer 1999; Kim et al. 2008) . h-Caldesmon has gained importance as a smooth-muscle differentiation marker in tumor diagnosis (Miettinen et al. 1999; Visée et al. 2005) , distinguishing myofibroblastic tumors from smooth-muscle tumors (Ceballos et al. 2000; Perez-Montiel et al. 2006; Qiu et al. 2008) . Some histopathological studies have also demonstrated the normal distribution of h-caldesmon in additional tissues, including the presence of caldesmon in human FDCs from normal and neoplastic lymph follicles (Tsunoda et al. 1999; Mesquita et al. 2009 ), but which cells express caldesmon in spleen and lymph nodes has not been demonstrated to date.
We have used a newly developed polyclonal antibody against mouse caldesmon, as well as antibodies commercially available, to investigate the expression of caldesmon in spleen and lymph nodes of mice and rats.
Materials and Methods

Animals
Nine female and male C57BL/6 JOlaHsd mice, age 4 to 12 months, were obtained from Harlan (Horst, The Netherlands). Six female and male Wistar rats, age 4 months, were bred in the Institute of Anatomy, Cologne, Germany; three female SCID mice (CB17/ Icr-Prkdc scid/Crl), age 8 weeks, were obtained from Charles River Laboratories (Sulzfeld, Germany). The animals were handled according to the guidelines of the animal care committee of the University of Cologne.
Gel Electrophoresis and Immunoblotting
Mouse and rat spleens, lymph nodes, and lungs were washed in Tris-base sodium chloride buffer, pH 7.6 (TBS), frozen in liquid nitrogen, and stored at 280C until use. For gel electrophoresis, tissues were homogenized in lysis buffer [50 mM Tris-base, 0.15 M NaCl, 5 mM EDTA, 1 mM PMSF (Sigma-Aldrich; Taufkirchen, Germany)] and centrifuged at 3000 3 g for 20 min at 4C. The supernatant was used, and the amount of protein in the supernatant was determined using the BCA protein assay kit (Perbio; Bonn, Germany). Proteins were separated by 6% SDS-PAGE, electroblotted onto a nitrocellulose membrane, and subsequently immersed in blocking buffer consisting of TBS containing 0.1% Tween 20 (TBST) and 5% non-fat dry milk for 1 hr at room temperature. The membranes were washed with TBS containing 0.1% Tween 20, followed by incubation overnight at 4C with primary antibodies, and diluted in TBST containing 5% non-fat dry milk. After washing in TBST, the blot was incubated with horseradish peroxidase (HRP)-coupled secondary antibodies to rabbit (Dako; Hamburg, Germany) or mouse IgG (Sigma-Aldrich), diluted in TBST containing 5% non-fat dry milk, for 1 hr at room temperature. Finally, the blot was washed again in TBST and developed with chemiluminescent substrate (Roche; Mannheim, Germany).
Tissue Processing
Animals were deeply anesthetized (0.02 g tribromethanol/100 g body weight intraperitoneally for rats; 0.055 g tribromethanol/100 g body weight intraperitoneally for mice), perfused via the left ventricle with 0.1 M PBS, pH 7.4, for 3 min, followed by 4% paraformaldehyde (PFA) or 4% PFA/0.2% picric acid for 15 min. Spleens and lymph nodes were removed, postfixed in the same fixative at 4C overnight, dehydrated, embedded in paraffin or frozen in isopentane in liquid N 2 , and cryoprotected in graded sucrose. Sections 4-7 mm thick were cut and mounted on silane (paraffin sections) or polysine-coated slides (frozen sections). To prepare acetone-fixed frozen sections, organs were removed without prior fixation, frozen in isopentane in liquid N 2 , cut, fixed in ice-cold acetone for 10 min, and air-dried for 45 min.
Antibodies
Four different antibodies against caldesmon were used. A rabbit polyclonal antibody was produced in the Institute of Physiology, University of Cologne, by immunization of rabbits with recombinant mouse h-caldesmon. h-Caldesmon was expressed as a Strep-Tag fusion protein in HEK-EBNA cells. Full-length h-caldesmon was injected into rabbits. The caldesmonspecific antibody was purified from rabbit serum by affinity chromatography. It was used at a concentration of 0.23 mg/ml for immunohistochemistry or 0.03 mg/ml for Western blot. A rabbit monoclonal caldesmon antibody was obtained from Abcam (Cambridge, UK). This antibody was raised against an epitope around phosphorylated Ser 789 , but is, according to the manufacturer, not phospho-specific (www.abcam.com/ab32330). It was used diluted 1:20 for immunohistochemistry or 1:250 for Western blot. A so-called human l-caldesmon monoclonal mouse antibody (clone 8/L-Caldesmon, catalog number 610660) was obtained from BD Transduction Laboratories (Heidelberg, Germany) and used diluted 1:100 for immunohistochemistry or 1:6000 for Western blot. This antibody was raised against a fragment of human l-caldesmon corresponding to aa 251-395, a sequence that is, however, present in lcaldesmon and h-caldesmon. A mouse monoclonal antibody to human uterus smooth-muscle extract (clone h-CD), according to the manufacturer specific for h-caldesmon, was obtained from Sigma-Aldrich (catalog number C 4562). It was diluted 1:250 for immunohistochemistry or 1:500 for Western blot. A polyclonal rabbit antibody against aa 36-42 of Ab42 (catalog number 44-344, Biosource; Nivelles, Belgium) and a mouse monoclonal to human paired helical filaments-tau, clone AT8 (code 90343, Innogenetics; Gent, Belgium), which were not expected to stain structures in normal spleen and lymph node, were used as controls to exclude unspecific Fc-receptor-mediated binding. Other antibodies used were a goat polyclonal to a carboxy-terminal epitope of mouse CD3 (sc-1127, Santa Cruz Biotechnology; Heidelberg, Germany) diluted 1:750, a mouse monoclonal to rat FDCs (clone ED5, catalog number MCA530R, Serotec; Düsseldorf, Germany) diluted 1:2000, a rat monoclonal to mouse FDCs (clone FDC-M1, catalog number 551320, BD Biosciences; Heidelberg, Germany) diluted 1:20, a rat monoclonal to mouse interdigitating dendritic cells (IDCs) (clone MIDC-8, catalog number MCA948, Serotec) diluted 1:15, and a rat monoclonal to mouse reticular fibroblasts (clone ER-TR7, catalog number MCA2402, Serotec) diluted 1:20.
Immunohistochemistry
Immunohistochemistry was performed using the avidin-biotin peroxidase method. Paraffin sections were deparaffinized in xylene, rehydrated, and pretreated by boiling three times for 5 min in citrate buffer (pH 6.0) in a microwave oven. After sections were washed in TBS for 5 min and blocked in 20% FBS 1 1% BSA for 45 min, primary antibodies diluted in TBS containing 3% non-fat dry milk were applied, and the sections were incubated overnight at 4C. After another three washes in TBS, they were incubated with the appropriate biotinylated secondary antibody for 30 min at room temperature [anti-rabbit IgG (Dianova; Hamburg, Germany) 1:400, anti-mouse IgG (Dianova) 1:250, antirat IgG (Dianova) 1:250, or anti-goat IgG (Linaris; Wertheim-Bettingen, Germany) 1:450]. Sections were again washed and incubated with an avidin-biotinylated HRP complex (ABC Elite Kit; Linaris) for another 30 min. Peroxidase activity was visualized by incubating the sections in a chromogen solution containing DAB intensified by the inclusion of 0.6% ammonium nickel sulfate (Fluka; Buchs, Switzerland) and 0.05% imidazol (Fluka), which resulted in a deep blue-gray reaction product.
Double Staining
For light microscopy, sections were consecutively stained with antibodies against IDCs and caldesmon. IDC staining (antibody MIDC-8) was done as described above. Color reaction was performed with the intensified DAB solution. Before staining for caldesmon, the peroxidase from the previous stain was blocked by incubating the sections in 0.3% H 2 O 2 in TBS for 30 min at room temperature. The polyclonal caldesmon primary antibody was followed by a peroxidase-coupled anti-rabbit secondary antibody (1:20; Dianova). A chromogen solution with DAB only produced a brown reaction product, indicating caldesmon immunoreactivity.
Immunofluorescence double labeling was performed with primary antibodies consecutively applied overnight at 4C. Incubation with the first primary antibody (clones h-CD, ED5, FDC-M1, and ER-TR7) was followed by incubation with biotinylated anti-mouse or anti-rat IgG (1:250; Dianova) for 30 min at room temperature and then with AlexaFluor 488-conjugated streptavidin (1:200; MoBiTec, Göttingen, Germany) for another 30 min at room temperature. The second primary antibody (caldesmon polyclonal) was detected with AlexaFluor 546-conjugated anti-rabbit IgG (1:400; MoBiTec). Autofluorescence was quenched by incubating the sections in a solution with 4 mM CuSO 4 /50 mM ammonium acetate for 30 min before the blocking step with 20% FBS/1% BSA.
Digital Imaging DAB-stained sections were examined with a BX40 microscope (Olympus; Hamburg, Germany) equipped with a ColorView II digital camera (Olympus Soft Imaging Solutions; Münster, Germany). Confocal laser scanning microscopy was performed with an LSM510 confocal microscope (Zeiss; Jena, Germany). Digital images were processed for contrast and brightness using Picture Publisher 8 (Micrografx) and Adobe Photoshop 5.0. Small tissue damages were retouched without altering the scientific information. Images were arranged in Adobe Photoshop 5.0. Images shown in Figures 5C and 5D are composed of two images taken with 310 objective lens. These images were processed for evenness of illumination.
Results
Testing of the Antibodies and Immunoblot Analysis of Caldesmon Isoform Expression in Spleen and Lymph Nodes
Caldesmon isoforms appear as proteins of 70 to 80 kDa and 120 to 150 kDa, different from their theoretical molecular mass because of aberrant migration
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in SDS-PAGE (Huber 1997) . The rabbit polyclonal, rabbit monoclonal calSer 789 , and mouse monoclonal cal 251-395 antibodies recognized a band at ?74 kDa in lysates of rat spleens and cervical lymph nodes, and a band at ?72 kDa in lysates of mouse spleens corresponding to the reported molecular mass of lcaldesmon. For mouse cervical lymph nodes, clear results were only obtained with the caldesmon polyclonal antibody. A band at 130 kDa, the molecular mass of h-caldesmon, was barely detectable (Figure 1) . Because h-caldesmon and l-caldesmon differ only by the lack of a central spacer region in l-caldesmon, specificity of the l-caldesmon antibody for l-caldesmon was unlikely. Indeed, this antibody recognized h-caldesmon in, e.g., lung, an organ with a higher relative amount of h-caldesmon (not shown) and was therefore used to detect all isoforms. We did not obtain a single band at 130 kDa with the monoclonal antibody against h-caldesmon as expected, neither in spleen or lymph node nor in lung, but did obtain a band at ?75 kDa, just above the bands detected by the other antibodies. This antibody labeled multiple bands when the concentration was slightly raised (not shown).
Caldesmon Is Highly Expressed by SMCs, Reticular Cells, and FDCs in Spleen and Lymph Nodes
We have compared PFA-fixed paraffin sections, acetone-, PFA-and PFA/picric acid-fixed frozen sections. Best results were obtained with PFA-fixed and PFA/ picric acid-fixed frozen sections with microwave pretreatment. There was only slight staining of nuclei when the cal 251-395 antibody was replaced by similar concentrated isotype-matched mouse IgG against phos-phorylated tau (antibody AT8). There was no staining when the caldesmon polyclonal antibody was replaced by polyclonal rabbit IgG of irrelevant specificity (anti-Ab42), indicating that binding of the caldesmon antibodies was not Fc-receptor mediated. Immunoreactivity was also absent when the primary antibodies were omitted (not shown).
We have obtained the same pattern of staining with spleens and lymph nodes from rats and mice. Immunoreactivity of the spleen with the antibody against h-caldesmon (clone h-CD) was confined to SMCs in the walls of larger blood vessels and in trabecula (Figures 2A-2C ). In addition to the anticipated immunoreactivity of SMCs, the reticular network of the spleen was strongly immunoreactive, with all three antibodies recognizing land h-caldesmon isoforms.
Comparably large reticular cells of the PALS displayed a strong immunoreaction ( Figures 2D and 2E ). Immunoreactivity of IDCs was excluded by double labeling ( Figure 2F) . A fine mesh of stained cells extended into the marginal zone and red pulp. The caldesmonpositive network overlapped with the ER-TR7 antigen, an extracellular matrix component secreted by reticular cells and incorporated into reticular fibers, which are enwrapped by reticular cell cytoplasm ( Figures 3A-3C ) (Katakai et al. 2004; Lokmic et al. 2008 ). There was prominent staining at the marginal sinus surrounding the follicles, similar to the location of MAdCAM-1positive cells in the murine spleen ( Figures 3D, 4A , and 4C) (Tanaka et al. 1996) . In the red pulp, large immunoreactive cells with the morphology of megakaryocytes were conspicuous ( Figure 2G ), in agreement with the known presence of caldesmon in platelets. In line with this, there was punctuate immunoreactivity between clusters of erythrocytes in sinus (not shown). Consistent with immunoreactivity of FDCs, we observed a weakly stained reticular pattern of B-cell follicles that was often stronger in the center of the follicle when polyclonal and cal 251-395 antibodies were used. However, we obtained only a little staining of the center of follicles with the calSer 789 antibody (Figure 2E ). Immunofluorescence double labeling of the caldesmonpositive reticulum in follicles with FDC-M1, a marker for mouse FDCs (Kosco et al. 1992) , confirmed that caldesmon is expressed by FDCs ( Figures 3D-3F ). Caldesmon-positive cells were also seen in the capsule. The presence of l-caldesmon in isolated T-lymphocytes from mouse spleen was demonstrated previously by immunoblotting (Mizushima et al. 1987) . We observed only weak immunostaining of lymphocytes of unclear significance just above background levels when frozen sections were used, most pronounced with the caldesmon polyclonal antibody.
Homozygous SCID mice lack functional B-and Tlymphocytes because of an inability to arrange antigen receptor genes (Schuler et al. 1986 ). Therefore, malpighian follicles of SCID spleens consist mainly of loose connective tissue containing a reticulin network, histiocytes, and fibroblasts (Custer et al. 1985) . Reticular cells of SCID mice displayed a reduced antigenic diversity, which reappeared after reconstitution with lymphocytes (Yoshida et al. 1993) . We have stained spleen sections for caldesmon to examine whether the (near complete) absence of lymphocytes within the reticular mesh of the white pulp would also influence the expression of caldesmon by reticular cells. The malpighian follicles of SCID spleens were smaller, compared with normal spleens, and displayed a dense network of caldesmon-positive reticular cells due to the lack of intervening lymphocytes ( Figures 4A-4F) .
In cervical and mesenteric lymph nodes, too, the reticular network was strongly immunostained with caldesmon antibodies recognizing land h-caldesmon isoforms in addition to SMCs, similar to the spleen. h-Caldesmon immunoreactivity was confined to the wall of a few blood vessels (not shown). Caldesmon-positive elongated cells were located in the capsule, underneath the subcapsular sinus, surrounding sinus and high endothelial venules, and in the medullary cords ( Figures 5A-5C ). As in spleen, there was also a strong reticular staining pattern in the center of several B-cell follicles with polyclonal ( Figure 5A ) and cal 251-395 antibodies (not shown), but not with the calSer 789 antibody ( Figure 5B ). Immunofluorescence double labeling for caldesmon and FDC-M1 or ED5, a marker for rat FDCs (Jeurissen and Dijkstra 1986) (not shown), confirmed that FDCs in lymph nodes were immunoreactive for caldesmon. Consecutive DAB-stained sections of normal rat cervical and mesenteric lymph nodes showed a good correspondence in the presence of ED5-and caldesmonpositive reticula in follicles ( Figures 5C and 5D ).
Discussion
The specificity of the immunolabeling for caldesmon has been confirmed by the use of four different poly- clonal and monoclonal antibodies against the same protein, recognizing different epitopes and produced in different species. The rabbit polyclonal, rabbit monoclonal calSer 789 , and mouse monoclonal cal antibodies stained the same bands corresponding to low-molecular-mass isoforms, whereas the highmolecular-mass isoform was barely detectable. This shows the preponderance of l-caldesmon in spleen Figure 5 (A,B) Seven-mm-thick, 4% PFA/0.2% picric acid-fixed consecutive frozen sections of a normal rat mesenteric lymph node stained with caldesmon polyclonal (A) or calSer 789 (B) antibodies shown at low magnification. The capsule, a large blood vessel, the deep cortex, and the medullary cords are immunoreactive. Follicles display stronger caldesmon immunoreactivity in the center (A); as in spleen, there is only minimal caldesmon immunoreactivity in the center of follicles with the calSer 789 antibody (B). (C,D) Four-mm-thick, 4% PFA/0.2% picric acidfixed, consecutive frozen sections of a normal rat mesenteric lymph node stained with the caldesmon polyclonal antibody (C) and for FDC (D), showing the colocalization of immunoreactive reticula (arrowheads) in the light zone of follicles. The deep cortex can be distinguished by the presence of large caldesmon-positive reticulum cells. The border between the deep cortex and the right follicle is indicated by arrows. Some small, round cells located mainly in the subcapsular sinus stain unspecifically because of their content of endogenous peroxidase. Bars: A,B 5 1 mm; C,D 5 200 mm. and lymph nodes. Other investigators have obtained a faint band at 77 kDa and a stronger band at 150 kDa, or only a faint band just below 80 kDa for rat spleen (Sobue et al. 1985; Dingus et al. 1986) . Our results also demonstrate that the molecular mass of l-caldesmon in spleens and lymph nodes of mice is lower than in rats. Western blots of various cell lines stained for caldesmon showed bands with molecular mass ranging from 71 to 77 kDa (Bretscher and Lynch 1985) , indicating, together with our results, tissue-and species-specific variation of the molecular mass of l-caldesmon.
The reticular meshwork of all compartments of spleen and lymph nodes was immunoreactive with the three antibodies recognizing land h-caldesmon isoforms, suggesting that a high level of expression of caldesmon is common to virtually all types of reticular cells, including those in the red pulp and FDCs. In contrast, reticular cells of the spleen display an enzyme and an antigenic heterogeneity demonstrated by the use of different antibodies identifying subsets of fibroblastic reticular cells in mouse and rat (Müller-Hermelink et al. 1974; Van den Berg et al. 1989; Yoshida et al. 1991;  see Table 3 in Balogh et al. 2004 for overview) . Several antibodies distinguish between reticular cells of T-and B-cell areas, suggesting that the antigenic diversity may depend upon the contact with lymphocytes. Experiments with SCID mice showed an influence of B-cells (Yoshida et al. 1993) . The widespread distribution of caldesmon and the expression in SCID mice suggest that the regulation of the expression of caldesmon is independent from lymphocytes.
In addition to SMCs, a higher content of caldesmon may be expected in other types of cells also containing a specialized contractile apparatus. At ultrastructural examination, reticulum cells display bundles of microfilaments (Pinkus et al. 1986; Satoh et al. 1997) . A subpopulation of reticulum cells expresses the smoothmuscle isoform of actin (a-SMA). In fibroblasts, the expression of a-SMA depends on the extracellular matrix and mechanical stress (Hinz et al. 2007) . In human and rat lymph nodes, a-SMA is expressed in parafollicular areas and in the deep cortex by cells with long cytoplasmic extensions (Toccanier-Pelte et al. 1987 ). In the human spleen, a-SMA is expressed by reticular cells bordering the white pulp and extending mesh-like into the marginal zone. In human and rat spleen, a-SMAcontaining reticular cells were also demonstrated in the PALS; but in follicles, these cells were rare, corresponding to sparse reticulum cells and reticulin fibers in this area. FDCs may replace a-SMA-positive reticular cells in germinal centers (Toccanier-Pelte et al. 1987; Satoh et al. 1997 Satoh et al. ,2009 Steiniger et al. 2001 ). In vivo imaging has shown that the FDC network displays a marked mobility, and FDCs in culture express a-SMA (Bajénoff et al. 2006; Muñoz-Fernández et al. 2006) . Another contractile protein, SMC myosin, has a similar distribution in spleen and may also be present in a reticular pattern in follicles of lymph nodes (Pinkus et al. 1986 ; but see Toccanier-Pelte et al. 1987) . When the distribution of a-SMA and SMC myosin is compared with the pattern of high expression of caldesmon in spleen and lymph nodes, expression of caldesmon is more widespread, corresponding better to the mesenchymal origin of cells.
As reported for human FDCs, we have found that rat and mouse FDCs express caldesmon. An obvious difference between the pattern of staining obtained with caldesmon polyclonal and cal 251-395 antibodies and the results obtained with the calSer 789 antibody is the lack of a more strongly stained reticulum in the center of follicles with the latter. This could be due either to the fact that the calSer 789 antibody is less sensitive or to the fact that it is more selective. The inability to stain FDCs seems to be absolute, because other cells were comparably stained. The monoclonal calSe 789 antibody is directed against an epitope at the extreme C terminus of caldesmon, close to the strong actin-binding domain. It is possible that this epitope is not sufficiently accessible in FDCs.
According to the known distribution of caldesmon isoforms, detection of h-caldesmon using clone h-CD was confined to SMCs in trabecula and in the wall of larger blood vessels, suggesting that caldesmon detected in reticular cells is the l-caldesmon isoform. This would be consonant with histopathological studies, which demonstrate that myofibroblasts express a-SMA but not h-caldesmon (Ceballos et al. 2000; Perez-Montiel et al. 2006; Qiu et al. 2008) . The relative proportions of l-caldesmon and h-caldesmon we have found in Western blot with antibodies recognizing both isoforms would be consistent with the expression of h-caldesmon by SMCs only. Thus, spleen and lymph nodes may contain a large population of strongly l-caldesmon-positive cells. l-Caldesmon in lymphocytes may contribute to the l-caldesmon band detected in Western blot as well (Mizushima et al. 1987) , but the amount of caldesmon may not be high enough to produce a clear immunohistochemical signal. However, because we could not demonstrate the specificity of the h-caldesmon antibody in Western blot, these conclusions remain somewhat uncertain. On the other hand, clone h-CD has been used in many histopathological studies as a marker for SMC-derived tumors, and staining of normal tissues with this antibody has been confined to SMCs and a few other cell types.
In conclusion, based on our immunohistochemical data, caldesmon is, in addition to SMCs, also highly expressed by reticular cells and FDCs in spleen and lymph nodes. The high amount of caldesmon in a-SMA-containing reticular cells may reflect an important role in the regulation of relaxation and contraction of these cells, especially during an immune response.
